Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 38 entries
Sorted by: Best Match Show Resources per page
[Prognosis, periods of hospitalization and work disability in type I diabetes mellitus].

Lebensversicherungs Medizin

Willms G, Berger M.
PMID: 2891007
Lebensversicher Med. 1987 Nov 01;39(6):169-72.

No abstract available.

Cite
Willms G, Berger M. Prognose, Krankenhausaufenthalts- und Arbeitsunfähigkeits-Zeiten bei Diabetes mellitus vom Typ I. [Prognosis, periods of hospitalization and work disability in type I diabetes mellitus]. Lebensversicher Med. 1987;39(6):169-72
Willms, G., & Berger, M. (1987). Prognose, Krankenhausaufenthalts- und Arbeitsunfähigkeits-Zeiten bei Diabetes mellitus vom Typ I. [Prognosis, periods of hospitalization and work disability in type I diabetes mellitus]. Lebensversicherungs Medizin, 39(6), 169-72.
Willms, G, and Berger, M. "Prognose, Krankenhausaufenthalts- und Arbeitsunfähigkeits-Zeiten bei Diabetes mellitus vom Typ I." [Prognosis, periods of hospitalization and work disability in type I diabetes mellitus]. Lebensversicherungs Medizin vol. 39,6 (1987): 169-72.
Willms G, Berger M. Prognose, Krankenhausaufenthalts- und Arbeitsunfähigkeits-Zeiten bei Diabetes mellitus vom Typ I. [Prognosis, periods of hospitalization and work disability in type I diabetes mellitus]. Lebensversicher Med. 1987 Nov 01;39(6):169-72. German. PMID: 2891007.
Copy Download .nbib Format: NLM
[Degenerative complications of diabetes].

Annales de pediatrie

de Menibus CH, Lestradet H.
PMID: 2069364
Ann Pediatr (Paris). 1991 Apr;38(4):277-84.

Even optimally treated insulin-dependent diabetes mellitus is responsible for a significant number of complications which impair daily activities and shorten life expectancy in most patients. The cause of these complications has been under investigation for many years. Substantial evidence...

Cite
de Menibus CH, Lestradet H. Complications dégénératives du diabète. [Degenerative complications of diabetes]. Ann Pediatr (Paris). 1991;38(4):277-84
de Menibus, C. H., & Lestradet, H. (1991). Complications dégénératives du diabète. [Degenerative complications of diabetes]. Annales de pediatrie, 38(4), 277-84.
de Menibus, C H, and Lestradet, H. "Complications dégénératives du diabète." [Degenerative complications of diabetes]. Annales de pediatrie vol. 38,4 (1991): 277-84.
de Menibus CH, Lestradet H. Complications dégénératives du diabète. [Degenerative complications of diabetes]. Ann Pediatr (Paris). 1991 Apr;38(4):277-84. French. PMID: 2069364.
Copy Download .nbib Format: NLM
Complications in 8793 cases of diabetes mellitus 14 years study in Bombay Hospital, Bombay, India.

Indian journal of medical sciences

Patel JC.
PMID: 2592029
Indian J Med Sci. 1989 Jul;43(7):177-83.

Complications in 8793 hospitalised cases of diabetes in 14 years were present in 81.8 percent. It was equal in both sexes. They did not depend upon religious dietary habits or on economic condition/status of the patient. Hypertension was present...

Cite
Patel JC. Complications in 8793 cases of diabetes mellitus 14 years study in Bombay Hospital, Bombay, India. Indian J Med Sci. 1989;43(7):177-83
Patel, J. C. (1989). Complications in 8793 cases of diabetes mellitus 14 years study in Bombay Hospital, Bombay, India. Indian journal of medical sciences, 43(7), 177-83.
Patel, J C. "Complications in 8793 cases of diabetes mellitus 14 years study in Bombay Hospital, Bombay, India." Indian journal of medical sciences vol. 43,7 (1989): 177-83.
Patel JC. Complications in 8793 cases of diabetes mellitus 14 years study in Bombay Hospital, Bombay, India. Indian J Med Sci. 1989 Jul;43(7):177-83. PMID: 2592029.
Copy Download .nbib Format: NLM
Juvenile Diabetes Foundation sees brighter future for diabetes patients.

American pharmacy

[No authors listed]
PMID: 3706123
Am Pharm. 1986 Apr;(4):14-5.

No abstract available.

Cite
Juvenile Diabetes Foundation sees brighter future for diabetes patients. Am Pharm. 1986;(4):14-5
(1986). Juvenile Diabetes Foundation sees brighter future for diabetes patients. American pharmacy, (4), 14-5.
"Juvenile Diabetes Foundation sees brighter future for diabetes patients." American pharmacy vol. ,4 (1986): 14-5.
Juvenile Diabetes Foundation sees brighter future for diabetes patients. Am Pharm. 1986 Apr;(4):14-5. PMID: 3706123.
Copy Download .nbib Format: NLM
Type I diabetes: a new risk factor for obstructive sleep apnea.

Revista portuguesa de pneumologia

Lorenzi-Filho G, Drager LF.
PMID: 25926366
Rev Port Pneumol (2006). 2015 Mar-Apr;21(2):53-4. doi: 10.1016/j.rppnen.2015.02.002. Epub 2015 Mar 09.

No abstract available.

Cite
Lorenzi-Filho G, Drager LF. Type I diabetes: a new risk factor for obstructive sleep apnea. Rev Port Pneumol (2006). 2015;21(2):53-4doi: 10.1016/j.rppnen.2015.02.002.
Lorenzi-Filho, G., & Drager, L. F. (2015). Type I diabetes: a new risk factor for obstructive sleep apnea. Revista portuguesa de pneumologia, 21(2), 53-4. https://doi.org/10.1016/j.rppnen.2015.02.002
Lorenzi-Filho, Geraldo, and Drager, Luciano F. "Type I diabetes: a new risk factor for obstructive sleep apnea." Revista portuguesa de pneumologia vol. 21,2 (2015): 53-4. doi: https://doi.org/10.1016/j.rppnen.2015.02.002
Lorenzi-Filho G, Drager LF. Type I diabetes: a new risk factor for obstructive sleep apnea. Rev Port Pneumol (2006). 2015 Mar-Apr;21(2):53-4. doi: 10.1016/j.rppnen.2015.02.002. Epub 2015 Mar 09. PMID: 25926366.
Copy Download .nbib Format: NLM
[The incidence of insulin dependent diabetes in children had increased].

Soins. Gynecologie, obstetrique, puericulture, pediatrie

Goddet B.
PMID: 8115937
Soins Gynecol Obstet Pueric Pediatr. 1993 Mar;(142):2.

No abstract available.

Cite
Goddet B. L'incidence du diabète insulino-dépendant de l'enfant a augmenté. [The incidence of insulin dependent diabetes in children had increased]. Soins Gynecol Obstet Pueric Pediatr. 1993;(142):2
Goddet, B. (1993). L'incidence du diabète insulino-dépendant de l'enfant a augmenté. [The incidence of insulin dependent diabetes in children had increased]. Soins. Gynecologie, obstetrique, puericulture, pediatrie, (142), 2.
Goddet, B. "L'incidence du diabète insulino-dépendant de l'enfant a augmenté." [The incidence of insulin dependent diabetes in children had increased]. Soins. Gynecologie, obstetrique, puericulture, pediatrie vol. ,142 (1993): 2.
Goddet B. L'incidence du diabète insulino-dépendant de l'enfant a augmenté. [The incidence of insulin dependent diabetes in children had increased]. Soins Gynecol Obstet Pueric Pediatr. 1993 Mar;(142):2. French. PMID: 8115937.
Copy Download .nbib Format: NLM
The diabetes ABC's. B stands for blood pressure. Part 3.

Diabetes forecast

Peterson K.
PMID: 14765422
Diabetes Forecast. 2003 Feb;56(2):49-50.

No abstract available.

Cite
Peterson K. The diabetes ABC's. B stands for blood pressure. Part 3. Diabetes Forecast. 2003;56(2):49-50
Peterson, K. (2003). The diabetes ABC's. B stands for blood pressure. Part 3. Diabetes forecast, 56(2), 49-50.
Peterson, Kevin. "The diabetes ABC's. B stands for blood pressure. Part 3." Diabetes forecast vol. 56,2 (2003): 49-50.
Peterson K. The diabetes ABC's. B stands for blood pressure. Part 3. Diabetes Forecast. 2003 Feb;56(2):49-50. PMID: 14765422.
Copy Download .nbib Format: NLM
Diabetes in people with an intellectual disability: a systematic review of prevalence, incidence and impact.

Diabetic medicine : a journal of the British Diabetic Association

McVilly K, McGillivray J, Curtis A, Lehmann J, Morrish L, Speight J.
PMID: 24824086
Diabet Med. 2014 Aug;31(8):897-904. doi: 10.1111/dme.12494.

AIMS: To establish the prevalence and incidence of type 1 and type 2 diabetes in people with an intellectual and developmental disability and determine their impact on health and well-being and to appraise the evidence available to inform good...

Cite
McVilly K, McGillivray J, Curtis A, et al. Diabetes in people with an intellectual disability: a systematic review of prevalence, incidence and impact. Diabet Med. 2014;31(8):897-904doi: 10.1111/dme.12494.
McVilly, K., McGillivray, J., Curtis, A., Lehmann, J., Morrish, L., & Speight, J. (2014). Diabetes in people with an intellectual disability: a systematic review of prevalence, incidence and impact. Diabetic medicine : a journal of the British Diabetic Association, 31(8), 897-904. https://doi.org/10.1111/dme.12494
McVilly, K, et al. "Diabetes in people with an intellectual disability: a systematic review of prevalence, incidence and impact." Diabetic medicine : a journal of the British Diabetic Association vol. 31,8 (2014): 897-904. doi: https://doi.org/10.1111/dme.12494
McVilly K, McGillivray J, Curtis A, Lehmann J, Morrish L, Speight J. Diabetes in people with an intellectual disability: a systematic review of prevalence, incidence and impact. Diabet Med. 2014 Aug;31(8):897-904. doi: 10.1111/dme.12494. PMID: 24824086.
Copy Download .nbib Format: NLM
Costs of insulin-dependent diabetes mellitus.

PharmacoEconomics

Hahl J, Simell TT, Simell OG, Sintonen H.
PMID: 10160085
Pharmacoeconomics. 1996 Jan;9(1):24-38. doi: 10.2165/00019053-199609010-00004.

Insulin-dependent diabetes mellitus (IDDM) is a prevalent chronic disease that causes marked personal and financial costs for patients, their families and society. Accurate information on costs of the disease is scarce. In this article, we review studies on disease...

Cite
Hahl J, Simell TT, Simell OG, et al. Costs of insulin-dependent diabetes mellitus. Pharmacoeconomics. 1996;9(1):24-38doi: 10.2165/00019053-199609010-00004.
Hahl, J., Simell, T. T., Simell, O. G., & Sintonen, H. (1996). Costs of insulin-dependent diabetes mellitus. PharmacoEconomics, 9(1), 24-38. https://doi.org/10.2165/00019053-199609010-00004
Hahl, J, et al. "Costs of insulin-dependent diabetes mellitus." PharmacoEconomics vol. 9,1 (1996): 24-38. doi: https://doi.org/10.2165/00019053-199609010-00004
Hahl J, Simell TT, Simell OG, Sintonen H. Costs of insulin-dependent diabetes mellitus. Pharmacoeconomics. 1996 Jan;9(1):24-38. doi: 10.2165/00019053-199609010-00004. PMID: 10160085.
Copy Download .nbib Format: NLM
Diabetic retinopathy screening in patients with diabetes mellitus in primary care: Incentives and barriers to screening attendance.

Diabetes research and clinical practice

van Eijk KN, Blom JW, Gussekloo J, Polak BC, Groeneveld Y.
PMID: 22137363
Diabetes Res Clin Pract. 2012 Apr;96(1):10-6. doi: 10.1016/j.diabres.2011.11.003. Epub 2011 Dec 03.

AIM: Although diabetic retinopathy (DR) screening is a basic component of diabetes care, uptake of screening programs is less than optimal. Because attendance rates and reasons for non-attendance in an unselected diabetes population are unknown, this study examines incentives...

Cite
van Eijk KN, Blom JW, Gussekloo J, et al. Diabetic retinopathy screening in patients with diabetes mellitus in primary care: Incentives and barriers to screening attendance. Diabetes Res Clin Pract. 2011;96(1):10-6doi: 10.1016/j.diabres.2011.11.003.
van Eijk, K. N., Blom, J. W., Gussekloo, J., Polak, B. C., & Groeneveld, Y. (2012). Diabetic retinopathy screening in patients with diabetes mellitus in primary care: Incentives and barriers to screening attendance. Diabetes research and clinical practice, 96(1), 10-6. https://doi.org/10.1016/j.diabres.2011.11.003
van Eijk, K N D, et al. "Diabetic retinopathy screening in patients with diabetes mellitus in primary care: Incentives and barriers to screening attendance." Diabetes research and clinical practice vol. 96,1 (2012): 10-6. doi: https://doi.org/10.1016/j.diabres.2011.11.003
van Eijk KN, Blom JW, Gussekloo J, Polak BC, Groeneveld Y. Diabetic retinopathy screening in patients with diabetes mellitus in primary care: Incentives and barriers to screening attendance. Diabetes Res Clin Pract. 2012 Apr;96(1):10-6. doi: 10.1016/j.diabres.2011.11.003. Epub 2011 Dec 03. PMID: 22137363.
Copy Download .nbib Format: NLM
Atherosclerosis in patients with type 1 diabetes.

Vnitrni lekarstvi

Karásek D.
PMID: 32013520
Vnitr Lek. 2020;65(12):775-782.

Type 1 diabetes is often associated with the early manifestation of atherosclerosis, which represents the morphological basis for macrovascular complications of diabetics. Atherosclerosis in patients with type 1 diabetes shows certain specific features that result from different proportions of...

Cite
Karásek D. Ateroskleróza u pacientů s diabetem 1. typu. Atherosclerosis in patients with type 1 diabetes. Vnitr Lek. 2020;65(12):775-782
Karásek, D. (2020). Ateroskleróza u pacientů s diabetem 1. typu. Atherosclerosis in patients with type 1 diabetes. Vnitrni lekarstvi, 65(12), 775-782.
Karásek, David. "Ateroskleróza u pacientů s diabetem 1. typu." Atherosclerosis in patients with type 1 diabetes. Vnitrni lekarstvi vol. 65,12 (2020): 775-782.
Karásek D. Ateroskleróza u pacientů s diabetem 1. typu. Atherosclerosis in patients with type 1 diabetes. Vnitr Lek. 2020;65(12):775-782. PMID: 32013520.
Copy Download .nbib Format: NLM
NAFLD/NASH and Diabetes.

Diabetes technology & therapeutics

Garg K, Brackett S, Hirsch IB, Garg SK.
PMID: 32069155
Diabetes Technol Ther. 2020 Feb;22:S174-S186. doi: 10.1089/dia.2020.2513.

No abstract available.

Cite
Garg K, Brackett S, Hirsch IB, et al. NAFLD/NASH and Diabetes. Diabetes Technol Ther. 2020;22:S174-S186doi: 10.1089/dia.2020.2513.
Garg, K., Brackett, S., Hirsch, I. B., & Garg, S. K. (2020). NAFLD/NASH and Diabetes. Diabetes technology & therapeutics, 22S174-S186. https://doi.org/10.1089/dia.2020.2513
Garg, Kavita, et al. "NAFLD/NASH and Diabetes." Diabetes technology & therapeutics vol. 22 (2020): S174-S186. doi: https://doi.org/10.1089/dia.2020.2513
Garg K, Brackett S, Hirsch IB, Garg SK. NAFLD/NASH and Diabetes. Diabetes Technol Ther. 2020 Feb;22:S174-S186. doi: 10.1089/dia.2020.2513. PMID: 32069155.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 38 entries